Detalhe da pesquisa
1.
Deterioration and Mortality Risk of COPD Patients Not Fitting into Standard GOLD Categories: Results of the COSYCONET Cohort.
Respiration;
100(4): 308-317, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33486499
2.
Health-related quality of life associates with change in FEV1 in COPD: results from the COSYCONET cohort.
BMC Pulm Med;
20(1): 148, 2020 May 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32471493
3.
Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study.
Respir Res;
20(1): 215, 2019 Oct 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31601216
4.
The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort.
Respir Res;
20(1): 257, 2019 Nov 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31727165
5.
Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities.
Clin Res Cardiol;
112(2): 177-186, 2023 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34331588
6.
Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment.
Sci Rep;
12(1): 1435, 2022 01 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35082306
7.
Impact of Lung Function and Exacerbations on Health-Related Quality of Life in COPD Patients Within One Year: Real-World Analysis Based on Claims Data.
Int J Chron Obstruct Pulmon Dis;
16: 2637-2651, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34588773
8.
Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET.
ERJ Open Res;
7(3)2021 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34430659
9.
Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort - Determinants and Consequences.
Int J Chron Obstruct Pulmon Dis;
16: 987-998, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33883892
10.
Effect of BMI on health care expenditures stratified by COPD GOLD severity grades: Results from the LQ-DMP study.
Respir Med;
175: 106194, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33166903
11.
Utilization and determinants of use of non-pharmacological interventions in COPD: Results of the COSYCONET cohort.
Respir Med;
171: 106087, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32917358
12.
Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort.
Int J Chron Obstruct Pulmon Dis;
15: 2787-2798, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33177816
13.
Relationship between clinical and radiological signs of bronchiectasis in COPD patients: Results from COSYCONET.
Respir Med;
172: 106117, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32891937
14.
Are health risk attitude and general risk attitude associated with healthcare utilization, costs and working ability? Results from the German KORA FF4 cohort study.
Health Econ Rev;
9(1): 26, 2019 Aug 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31471778
15.
Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET.
Int J Chron Obstruct Pulmon Dis;
14: 1423-1439, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31308648
16.
Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort.
Patient Prefer Adherence;
13: 1711-1721, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31631986
17.
CAT score single item analysis in patients with COPD: Results from COSYCONET.
Respir Med;
159: 105810, 2019 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31739262